The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Friday, November 03, 2017
Janssen Research & Development
Janssen announced additional analyses from CANVAS clinical trial program showing INVOKANA improved renal outcomes and demonstrated potential renal ...
read more
Thursday, November 02, 2017
Symic Bio announced results from the Phase 1/2 SHIELD trial evaluating SB-030, a locally administered therapeutic, in patients with peripheral ...
read more
Thursday, November 02, 2017
Compugen announced the initiation of a multi-year cancer immunotherapy research collaboration with Mount Sinai.
read more
Wednesday, November 01, 2017
Inhibrx announced a collaboration with CARB-X focused on funding the advancement of products to treat drug-resistant bacteria.
read more
Wednesday, November 01, 2017
University of Maryland's IBBR will collaborate with the Frederick National Laboratory for Cancer Research to explore candidate vaccines against HPV.
read more
Wednesday, November 01, 2017
Biohaven announced the FDA has notified the company it may proceed with its clinical investigation of sublingual BHV-0223 as a potential treatment for...
read more
Tuesday, October 31, 2017
The Crohn's & Colitis Foundation has received a $5 million pledge to fund research ideas in the early stage of exploration that could advance the ...
read more
Tuesday, October 31, 2017
Pivotal phase 3 placebo-controlled ENLIVEN study of pexidartinib met its primary endpoint of tumor response as measured by tumor size reduction in ...
read more
Tuesday, October 31, 2017
AstraZeneca Pharmaceuticals
AstraZeneca and MedImmune announced the expansion of their clinical collaboration with Incyte.
read more
Tuesday, October 31, 2017
The Phase 3 investigational study evaluating dupilumab in adults and adolescents with severe, steroid-dependent asthma met its primary endpoint and ...
read more
Merck announced financial results for the third quarter of 2017.
read more
Lin BioScience announced the FDA has granted orphan drug designation to LBS-008, a first-in-class oral therapy for the treatment of Stargardt Disease.
read more
Wednesday, October 25, 2017
Alligator Bioscience and Aptevo Therapeutics announced further details of the companies' collaboration on ALG.APV-526, a bispecific antibody targeting...
read more
Wednesday, October 25, 2017
Janssen’s once-daily, single tablet combination therapy SYMTUZA has shown to be both highly effective and well-tolerated in treating antiretroviral-...
read more
Tuesday, October 24, 2017
Biohaven may proceed with its clinical investigation of trigriluzole, a novel glutamate modulator, as a potential treatment for patients with OCD.
read more